Can echocardiography and ECG discriminate hereditary transthyretin V30M amyloidosis from hypertrophic cardiomyopathy?. (September 2015)

• Record Type: Journal Article
• Authors: Gustavsson, Sandra; Granåsen, Gabriel; Grönlund, Christer; Wiklund, Urban; Mörner, Stellan; Henein, Michael; Suhr, Ole B; Lindqvist, Per
• Is Part Of: Amyloid. Volume 22:Number 3(2015:Sep.)
• Page Start: 163
• Page End: 170
• Publication Date: 2015-09
• Subjects: Amyloidosis -- Periodicals; 616.3995
• Languages: English
• ISSNs: 1350-6129

Abstract

<abstract> <title>Abstract</title> <p> <italic>Objective</italic>: Hereditary transthyretin (ATTR) amyloidosis with increased left ventricular wall thickness could easily be misdiagnosed by echocardiography as hypertrophic cardiomyopathy (HCM). Our aim was to create a diagnostic tool based on echocardiography and ECG that could optimise identification of ATTR amyloidosis.</p> <p> <italic>Methods</italic>: Data were analysed from 33 patients with biopsy proven ATTR amyloidosis and 30 patients with diagnosed HCM. Conventional features from ECG were acquired as well as two dimensional and Doppler echocardiography, speckle tracking derived strain and tissue characterisation analysis. Classification trees were used to select the most important variables for differentiation between ATTR amyloidosis and HCM.</p> <p> <italic>Results</italic>: The best classification was obtained using both ECG and echocardiographic features, where a QRS voltage >30 mm was diagnostic for HCM, whereas in patients with QRS voltage <30 mm, an interventricular septal/posterior wall thickness ratio (IVSt/PWt) >1.6 was consistent with HCM and a ratio <1.6 supported the diagnosis of ATTR amyloidosis. This classification presented both high sensitivity (0.939) and specificity (0.833).</p> <p> <italic>Conclusion</italic>: Our study proposes an easily interpretable classification method for the differentiation between HCM and increased left ventricular myocardial thickness due to ATTR amyloidosis. Our combined echocardiographic and ECG model could increase the ability to identify ATTR cardiac amyloidosis in clinical practice.</p> </abstract>